Sanofi Accused Of Fraud In Clinical Trial Of Drug

By Brendan Pierson (February 15, 2008, 12:00 AM EST) -- Allegations that Sanofi-Aventis Pharmaceuticals deliberately concealed potential harmful effects of its antibiotic Ketek, which has been linked to liver damage, continued to pile up Tuesday as the U.S. House Committee on Energy and Commerce heard more witnesses....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!